XML 59 R43.htm IDEA: XBRL DOCUMENT

Parent-Only Financial Statements (Tables) - Parent [Member]

12 Months Ended

Dec. 31, 2023

Parent-Only Financial Statements (Tables) [Line Items]

Schedule of Condensed Balance Sheets

		As of December 31,
		2022			2023
		RMB			RMB			US$
ASSETS/(LIABILITIES)
Cash and cash equivalents		25,769			1,205,993			170,273
Prepayments		—			13,776			1,945
Due from intercompany		380,321,338			456,041,568			64,388,096
Investment in subsidiaries		(215,932,707	)		(471,994,335	)		(66,640,453	)
TOTAL ASSETS (LIABILITIES)		164,414,400			(14,732,998	)		(2,080,139	)
SHAREHOLDERS’ EQUITY (DEFICIT)
Shareholders’ equity (deficit):
Class A ordinary shares ($0.0002 par value; 121,410,923 shares authorized; 27,159,258 and 41,927,302 shares issued as of December 31, 2022 and 2023, respectively; 27,159,258 and 37,242,359 shares outstanding as of December 31, 2022 and 2023, respectively)*		35,425			50,106			7,074
Class B ordinary shares ($0.0002 par value; 28,589,078 shares authorized; 28,589,078 shares issued and outstanding as of December 31, 2022 and 2023)*		36,894			36,894			5,209
Additional paid-in capital		354,803,564			428,310,028			60,472,705
Accumulated deficit		(199,207,921	)		(452,031,693	)		(63,821,945	)
Statutory reserves		6,647,109			6,647,109			938,499
Accumulated other comprehensive income		2,099,329			2,254,558			318,319
TOTAL NANO LABS LTD SHAREHOLDERS’ EQUITY (DEFICIT)		164,414,400			(14,732,998	)		(2,080,139	)

* After giving effect of the reverse stock split, see Note 1.

Schedule of Condensed Statements of Operations and Comprehensive Income (Loss)

		For the years ended December 31,
		2021			2022			2023
		RMB			RMB			RMB			US$
Net revenues		—			—			—			—
Operating expenses:
Selling and marketing expenses		980			—			—			—
General and administrative expenses		306,775			5,822,906			471,664			66,594
Total operating expenses		307,755			5,822,906			471,664			66,594
Loss from operations		(307,755	)		(5,822,906	)		(471,664	)		(66,594	)
Finance income		—			66,144			110,971			15,668
Investment income		—			53,809			—			—
Income (loss) from investment in subsidiaries		(174,636,729	)		36,821,839			(252,463,079	)		(35,645,033	)
Net income (loss) attributable to Nano Labs Ltd		(174,944,484	)		31,118,886			(252,823,772	)		(35,695,959	)
Comprehensive income (loss):
Net income (loss)		(174,944,484	)		31,118,886			(252,823,772	)		(35,695,959	)
Other comprehensive income (loss)
Foreign currency translation adjustment		(2,467,327	)		4,566,656			155,229			21,917
Total comprehensive income (loss) attributable to Nano Labs Ltd		(177,411,811	)		35,685,542			(252,668,543	)		(35,674,042	)

Schedule of Condensed Statements of Cash Flows

		For the years ended December 31,
		2021			2022			2023
		RMB			RMB			RMB			US$
Net cash provided by (used in) operating activities		(535,017	)		3,911,561			344,012			48,571
Net cash used in investing activities		(201,554,446	)		(155,900,936	)		(68,918,960	)		(9,730,605	)
Net cash provided by financing activities		201,251,124			144,043,186			72,802,734			10,278,952
Effect of exchange rate changes on cash and cash equivalents		926,910			7,883,387			(3,047,562	)		(430,284	)
Net increase (decrease) in cash and cash equivalents		88,571			(62,802	)		1,180,224			166,634
Cash and cash equivalents at beginning of the year		—			88,571			25,769			3,639
Cash and cash equivalents at end of the year		88,571			25,769			1,205,993			170,273